Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Thorax. 2024 Jan 18;79(2):163–168. doi: 10.1136/thorax-2022-218670

Table 3.

Adjusted odds ratios (OR) relating past-30-day e-cigarette use to respiratory symptoms, from mixed-effect logistic regression models.

Model Wheeze Bronchitic Symptoms Shortness of Breath
Concurrent wave e-cigarette use (lag 0) OR (95%CI) OR (95%CI) OR (95%CI)
Model 1a 1.81 (1.28, 2.56) 2.06 (1.58, 2.69) 1.78 (1.23, 2.57)
Model 2b 1.41 (0.99, 2.01) 1.55 (1.18, 2.05) 1.48 (1.01, 2.18)
Prior wave e-cigarette use (lag 1)
Model 1a 2.17 (1.41, 3.35) 1.51 (1.07, 2.14) 1.59 (1.08, 2.34)
Model 2b 1.77 (1.14, 2.74) 1.23 (0.86, 1.74) 1.41 (0.96, 2.09)

Note.

a

= Model included participant-level random intercept and adjustment for wave, age, sex, race, and parental education.

b

= additional adjustment for concurrent (lag 0) use of cigarettes, cannabis, and secondhand exposure to e-cigarettes, cigarettes, and cannabis.